NCT04694716

Determination of Serum Trace Element and Physical Activity Levels in COVID-19

Completed Last updated 31 August 2021

What this trial tests

trial testing No intervention in Covid19 in 40 participants. Completed in 15 August 2021.

Timeline

6 January 2021

Primary endpoint
15 May 2021

15 August 2021

Quick facts

Lead sponsor	Izmir Bakircay University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	6 January 2021
Primary completion	15 May 2021
Estimated completion	15 August 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• No intervention

Conditions studied

• Covid19 — all drugs for Covid19 →

Sponsor

Izmir Bakircay University

Who can join

Adults 35 to 65, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The pathogenesis of COVID-19, which is caused by the coronavirus species, which has become a global health problem affecting the lives of billions of people worldwide and is a member of the Betacoronavirus genus, is not fully understood. Although its pathogenesis is thought to be multifactorial, it results in a systemic hyperinflammatory response and associated thromboembolic complications in severe cases. It is thought that some vitamins and nutrients may be beneficial for COVID-19 infected patients due to their anti-inflammatory and antioxidant properties. Vitamins such as A, B, C, D, E and folate; trace elements such as iron, zinc, magnesium, selenium and copper play important roles in supporting both innate and adaptive immune systems, and studies have shown that the trace elements investigated have important roles in COVID-19. For this reason, it is important to investigate the levels of trace elements. In addition, while the disease spreads all over the world, individuals are required to stay at home for a long time against the risk of contamination. Due to these isolation and limitations, physical activity levels decrease in individuals. As reductions in the level of physical activity may cause possible secondary symptoms, another parameter is to determine the physical activity level in order to prevent the potential harmful effects of these protective lifestyle regulations related to COVID-19 and to prevent the restrictions from causing physical inactivity. This study is planning to conduct between January and February 2021 in order to compare the trace element levels in blood samples and physical activity levels of patients with COVID-19 (SARS CoV-2) who applied to Izmir Bakircay University Cigli Training and Research Hospital (Cigli Regional Training Hospital) and hospitalized in the COVID-19 service. It was planned as a prospective, randomized controlled trial. Research data will be obtained from blood samples taken from participants. In addition, data on physical activity levels will be collected through a questionnaire. After analyzing the data obtained from the research with appropriate statistical methods, the data will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.